US FDA approves Gilead's COVID-19 drug for young children
April 26, 2022 at 09:38 AM EDT
The FDA has granted full approval to Gilead's remdesivir COVID-19 treatment for children 28 days and older.
Workboat Indexes
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
